Ipilimumab vs Selenomethionine Se 75

## Ipilimumab vs Selenomethionine Se 75: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Selenomethionine Se 75**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Selenomethionine Se 75 — N/A.

## Chemical Properties

**Type**: Ipilimumab — Antibody; Selenomethionine Se 75 — Small molecule.